Scotiabank lowered the firm’s price target on AvePoint (AVPT) to $17 from $22 and keeps an Outperform rating on the shares. The firm notes there were pluses and minuses to the quarter, with ARR only in line with consensus and no guidance raise paired with ARR growth and impressive operating margins, the analyst tells investors. With shares down 20% over the past three months, the firm believes the shares look “attractive.”
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AVPT:
- AvePoint price target lowered to $18 from $22 at Evercore ISI
- AvePoint price target lowered to $18 from $22.50 at Cantor Fitzgerald
- AvePoint price target lowered to $16 from $17 at Baird
- AvePoint’s Strong Performance and Strategic AI Positioning Earns Buy Rating
- AvePoint Reports Strong Q3 2025 Financial Growth